Growth capital

Asia Awards: Firm of the Year - KKR

KKR closed its second pan-Asia fund at $6 billion and announced investments of $1.8 billion and distributions of $1.2 billion for the year to September. Capstone, the firm’s operating unit, was a factor in each area

Adding extra: China bolt-on acquisitions

Private equity firms are exploring various strategies to help Chinese companies expand overseas. Bolt-on acquisitions are a proven approach in some markets, but that doesn’t mean they work for corporate China

Temasek buys stake in India's Eros International

Temasek Holdings has made its first foray into India's Bollywood movie industry as Fullerton Fund Management - a unit of the Singapore sovereign fund - acquired a stake in local film distributor Eros International.

KKR to invest $200m in Indian drug maker Gland Pharma

KKR has agreed to buy a minority stake in Gland Pharma, an Indian injectable drugs manufacturer, for approximately $200 million. The investment facilitates the exit of Invascent Capital's Evolvence India Life Sciences Fund (EILSF).

Light at the end of the tunnel

Indian private equity has taken a beating in recent years. As the excesses of the industry’s overcrowded GP population catches up with the realities of a sluggish economy and a weakening currency, it is no surprise that fundraising has been slower in...

Australia's HighPoint Capital invests in Brand New Media

HighPoint Capital has acquired a significant minority shareholding in Brand New Media (BNM), a Sydney-headquartered business that runs digital channels for brands and broadcasters. Its partners include Seven West Media in Australia, New Zealand’s national...

CDC, IDFC co-invest in India's Green Infra

CDC Group will invest up to $25 million in Green Infra, an independent renewable power producer backed by IDFC Alternatives. The GP will add another $23.89 million as part of a $125 million financing round.

LPs say Asian GPs lack long-term investment model - AVCJ Forum

Global institutional investors are becoming more cautious in allocating capital to Asian private equity funds, citing the region's weakening economic performance and concerns that GPs’ short-term investment horizons are not beneficial to the broader development...

  • LPs
H&Q invests $90m Monster-owned JobKorea

H&Q Korea has agreed to buy a 49.9% interest in JobKorea, the South Korean operation of Monster Worldwide, for an aggregate purchase price of $90 million. Monster will retain management control of the business, with H&Q supporting regional expansion efforts....

Investment: Southeast Asia's family footholds

By most measures, Southeast Asia is under-penetrated by private equity. If deal flow expectations are to be met, investors must tap local networks for openings in and around the family conglomerates

Asia fundraising: Size matters?
Asia fundraising: Size matters?

While a select group of GPs are able to raise large funds at short order in Asia, the small and mid-cap space is hollowing out. It is in parts cyclical and a function of broader changes in the post-financial crisis LP base

Exits: Stuck in China
Exits: Stuck in China

The weak IPO market has left many China PE firms holding assets for longer than expected. While growth deals will remain dominant, there will be change in how and with whom they are done

CNEI invests $25.4m in Chinese drug developer

China New Enterprise Investment (CNEI) has acquired a 17% stake in Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ) for $25.4 million, becoming the second-largest shareholder in the Shanghai based bio-pharmaceutical firm.

Chinese digital magazine Viva receives $20m round

Viva, a Chinese digital magazine operator, has received a $20 million Series C round of financing from an undisclosed French investment institution. Minhong Yu, founder of Chinese education provider New Oriental, also participated in the round.

Affinity seals $123m dairy JV with Chinese SOE

Affinity Equity Partners has invested $123 million in a dairy farming joint venture with a Chinese state-owned enterprise (SOE). It represents the 12th and final commitment from the GP’s third pan-Asian fund and comes as Fund IV is said be nearing a final...

Fosun VC, ChinaRock back Shijiebang Series A round

Fosun Venture Capital Investment, Fosun Group’s VC arm, and US-based ChinaRock Capital Management have invested in a Series A round of financing for online travel site Shijiebang. Angel investor Jerry Yang, co-founder and former CEO of Yahoo, also participated...

Affinity bets again on the protein theory

Having bought New Zealand poulty producer Tegel Foods and Australian deli meats specialist Primo Smallgoods, Affinity Equity Partners’ third pan-regional fund is already heavily invested in the Asian “protein theory.” Both companies are looking to distribute...